No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 11.560
- +0.210+1.85%
Close Dec 20 16:00 ET
- 11.700
- +0.140+1.21%
Post 20:01 ET
1.21BMarket Cap-4.23P/E (TTM)
11.790High11.150Low2.87MVolume11.310Open11.350Pre Close33.09MTurnover3.42%Turnover RatioLossP/E (Static)104.36MShares32.52552wk High3.66P/B969.18MFloat Cap11.15052wk Low--Dividend TTM83.84MShs Float67.480Historical High--Div YieldTTM5.64%Amplitude7.565Historical Low11.539Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'
Rocket Pharmaceuticals Initiated at Buy by Jefferies
Jefferies Initiates Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Announces Target Price $29
Leerink Partners Maintains Rocket Pharmaceuticals(RCKT.US) With Buy Rating, Cuts Target Price to $40
Express News | Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
Rocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx Conference
Heat List
US
Overall
Symbol
Price
% Chg
No Data